AstraZeneca, Plaintiffs to Argue FDA Bill's Effect on Preemption

ORLANDO, Fla. - A recent FDA reform bill signed into law by President George W. Bush will be the focus of the latest round of briefing in the battle over whether Seroquel personal injury claims are preempted by the Food, Drug & Cosmetic Act. In Re: Seroquel Products Liability Litigation, MDL No. 1769 (M.D. Fla.).

The Florida U.S. District Court overseeing MDL proceedings for claims related to the atypical antipsychotic recently granted motions by plaintiffs and defendant AstraZeneca to allow for supplemental briefing on what impact, if any, the new law may have on the preemption argument.

H.R. 3580, the …